首页 > 最新文献

Chirurgia最新文献

英文 中文
The Decline of Open, Laparoscopic, and Robotic Splenectomies: A Single Center Experience. 开腹、腹腔镜和机器人脾切除术的衰退:单中心经验。
IF 0.6 Q4 SURGERY Pub Date : 2024-04-01 DOI: 10.21614/chirurgia.2024.v.119.i.2.p.184
Beatrice M Tivadar, Corina E Minciună, Daniel Coriu, Anca Coliţă, Cătălin Vasilescu

Background: Splenectomy has been performed for various indications from haematological diseases to benign cysts and tumours, and for splenic traumatic injuries. However, there has been a steady decline in splenectomies in the last 20 years. The aim of this study is to establish the reasons behind this decline in splenectomy and to analyse them based on indication, type of splenectomy, and manner of approach (open, laparoscopic or robotic). Material and Methods: This is a retrospective study of a single centre experience of all the splenectomies, both total and partial, performed in the Department of General Surgery of Fundeni Clinical Institute (Bucharest) between 2002 and 2023. Only surgeries for primary splenic diseases were selected, splenic resections as part of other major operations were not included. Results: Between 2002 and 2023, 876 splenectomies were performed in the Department of General Surgery of Fundeni Clinical Institute (Bucharest). Most splenectomies (n=245) were performed for immune thrombocytopenic purpura (ITP), followed by benign tumours and cysts (n=136), lymphoma (n=119), hypersplenism due to cirrhosis (n=107) and microspherocytosis (n=95). Other indications included myelodysplastic syndrome (n=39), trauma (n=35), thalassemia (n=22), leukaemia (n=18) and also there were 60 splenectomies that were performed for hypersplenism of unknown cause. There were 795 total splenectomies (TS) and 81 partial splenectomies (PS). There was a decline in the number of splenectomies both TS and PS for all these indications, most notably in the case of ITP, microspherocytosis and hypersplenism due to cirrhosis with no splenectomies performed for these indications since 2020. Conclusion: With the development of new lines of treatment, advances in interventional radiology and in surgery with the spleen parenchyma sparing options, the need for total splenectomy has been greatly reduced which is reflected in the decline in the number of splenectomies performed in the last 20 years in our clinic.

背景:脾切除术的适应症多种多样,从血液病到良性囊肿和肿瘤,以及脾外伤。然而,在过去 20 年中,脾切除术的数量持续下降。本研究旨在确定脾脏切除术减少的原因,并根据适应症、脾脏切除术的类型和方法(开腹、腹腔镜或机器人)进行分析。材料和方法:这是一项单一中心经验的回顾性研究,涉及 2002 年至 2023 年间在布加勒斯特 Fundeni 临床研究所普外科进行的所有脾脏切除术,包括全切和部分切除术。研究仅选取了原发性脾脏疾病的手术,未包括作为其他大型手术一部分的脾脏切除术。结果:2002 年至 2023 年间,布加勒斯特 Fundeni 临床研究所普外科共进行了 876 例脾切除手术。大多数脾切除术(245 例)是针对免疫性血小板减少性紫癜(ITP)进行的,其次是良性肿瘤和囊肿(136 例)、淋巴瘤(119 例)、肝硬化引起的脾功能亢进(107 例)和微球形红细胞增多症(95 例)。其他适应症包括骨髓增生异常综合征(39 例)、外伤(35 例)、地中海贫血(22 例)、白血病(18 例),还有 60 例因不明原因的脾功能亢进而进行的脾切除术。全脾切除术(TS)795 例,部分脾切除术(PS)81 例。所有这些适应症的脾切除术(TS)和部分脾切除术(PS)的数量都有所下降,其中以 ITP、微球形红细胞增多症和肝硬化引起的脾功能亢进最为明显,自 2020 年以来,这些适应症已不再进行脾切除术。结论随着新治疗方法的发展、介入放射学的进步以及保留脾实质的手术选择,对全脾切除术的需求已大大降低,这反映在过去 20 年中我们诊所进行的脾切除术数量的下降上。
{"title":"The Decline of Open, Laparoscopic, and Robotic Splenectomies: A Single Center Experience.","authors":"Beatrice M Tivadar, Corina E Minciună, Daniel Coriu, Anca Coliţă, Cătălin Vasilescu","doi":"10.21614/chirurgia.2024.v.119.i.2.p.184","DOIUrl":"https://doi.org/10.21614/chirurgia.2024.v.119.i.2.p.184","url":null,"abstract":"<p><p><b>Background:</b> Splenectomy has been performed for various indications from haematological diseases to benign cysts and tumours, and for splenic traumatic injuries. However, there has been a steady decline in splenectomies in the last 20 years. The aim of this study is to establish the reasons behind this decline in splenectomy and to analyse them based on indication, type of splenectomy, and manner of approach (open, laparoscopic or robotic). Material and <b>Methods:</b> This is a retrospective study of a single centre experience of all the splenectomies, both total and partial, performed in the Department of General Surgery of Fundeni Clinical Institute (Bucharest) between 2002 and 2023. Only surgeries for primary splenic diseases were selected, splenic resections as part of other major operations were not included. <b>Results:</b> Between 2002 and 2023, 876 splenectomies were performed in the Department of General Surgery of Fundeni Clinical Institute (Bucharest). Most splenectomies (n=245) were performed for immune thrombocytopenic purpura (ITP), followed by benign tumours and cysts (n=136), lymphoma (n=119), hypersplenism due to cirrhosis (n=107) and microspherocytosis (n=95). Other indications included myelodysplastic syndrome (n=39), trauma (n=35), thalassemia (n=22), leukaemia (n=18) and also there were 60 splenectomies that were performed for hypersplenism of unknown cause. There were 795 total splenectomies (TS) and 81 partial splenectomies (PS). There was a decline in the number of splenectomies both TS and PS for all these indications, most notably in the case of ITP, microspherocytosis and hypersplenism due to cirrhosis with no splenectomies performed for these indications since 2020. Conclusion: With the development of new lines of treatment, advances in interventional radiology and in surgery with the spleen parenchyma sparing options, the need for total splenectomy has been greatly reduced which is reflected in the decline in the number of splenectomies performed in the last 20 years in our clinic.</p>","PeriodicalId":10171,"journal":{"name":"Chirurgia","volume":"119 2","pages":"184-190"},"PeriodicalIF":0.6,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140921199","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Molecular Deciphering of Colorectal Cancer: Exploring Molecular Classifications and Analyzing the Interplay among Molecular Biomarkers MMR/MSI, KRAS, NRAS, BRAF and CDX2 - A Comprehensive Literature Review. 结直肠癌的分子解密:探索分子分类并分析分子生物标记物 MMR/MSI、KRAS、NRAS、BRAF 和 CDX2 之间的相互作用 - 综合文献综述。
IF 0.8 Q4 SURGERY Pub Date : 2024-04-01 DOI: 10.21614/chirurgia.2024.v.119.i.2.p.136
Andreea-Corina Ilie-Petrov, Daniel-Alin Cristian, Andrei Sebastian Diaconescu, Andrei Chitul, Angela Blajin, Andrei Popa, Draga-Maria Mandi, Razvan Negreanu, Corina Vieru, Rareş Vrîncianu, Carmen Maria Ardeleanu

Background: Colorectal cancer (CRC) exhibits molecular and morphological diversity, involving genetic, epigenetic alterations, and disruptions in signaling pathways. This necessitates a comprehensive review synthesizing recent advancements in molecular mechanisms, established biomarkers, as well as emerging ones like CDX2 for enhanced CRC assessment. Material and Methods: This review analyzes the last decade's literature and current guidelines to study CRC's molecular intricacies. It extends the analysis beyond traditional biomarkers to include emerging ones like CDX2, examining their interaction with carcinogenic mechanisms and molecular pathways, alongside reviewing current testing methodologies. Results: A multi-biomarker strategy, incorporating both traditional and emerging biomarkers like CDX2, is crucial for optimizing CRC management. This strategy elucidates the complex interaction between biomarkers and the tumor's molecular pathways, significantly influencing prognostic evaluations, therapeutic decision-making, and paving the way for personalized medicine in CRC. Conclusions: This review proposes CDX2 as an emerging prognostic biomarker and emphasizes the necessity of thorough molecular profiling for individualized treatment strategies. By enhancing CRC treatment approaches and prognostic evaluation, this effort marks a step forward in precision oncology, leveraging an enriched understanding of tumor behavior.

背景:结直肠癌(CRC)在分子和形态上表现出多样性,涉及基因、表观遗传学改变以及信号通路的破坏。因此,有必要对分子机制的最新进展、已有的生物标志物以及 CDX2 等新兴生物标志物进行全面综述,以加强对 CRC 的评估。材料与方法:本综述分析了近十年来研究 CRC 复杂分子机制的文献和现行指南。它将分析范围从传统的生物标志物扩展到 CDX2 等新兴生物标志物,研究它们与致癌机制和分子途径的相互作用,同时回顾当前的检测方法。结果:多生物标志物策略既包括传统生物标志物,也包括 CDX2 等新兴生物标志物,对于优化 CRC 管理至关重要。这一策略阐明了生物标志物与肿瘤分子通路之间复杂的相互作用,对预后评估和治疗决策产生了重大影响,并为 CRC 的个性化医疗铺平了道路。结论本综述提出 CDX2 是一种新兴的预后生物标志物,并强调了全面的分子图谱分析对于个体化治疗策略的必要性。通过加强 CRC 治疗方法和预后评估,这项工作标志着精准肿瘤学向前迈进了一步,同时也丰富了对肿瘤行为的理解。
{"title":"Molecular Deciphering of Colorectal Cancer: Exploring Molecular Classifications and Analyzing the Interplay among Molecular Biomarkers MMR/MSI, KRAS, NRAS, BRAF and CDX2 - A Comprehensive Literature Review.","authors":"Andreea-Corina Ilie-Petrov, Daniel-Alin Cristian, Andrei Sebastian Diaconescu, Andrei Chitul, Angela Blajin, Andrei Popa, Draga-Maria Mandi, Razvan Negreanu, Corina Vieru, Rareş Vrîncianu, Carmen Maria Ardeleanu","doi":"10.21614/chirurgia.2024.v.119.i.2.p.136","DOIUrl":"10.21614/chirurgia.2024.v.119.i.2.p.136","url":null,"abstract":"<p><p><b>Background:</b> Colorectal cancer (CRC) exhibits molecular and morphological diversity, involving genetic, epigenetic alterations, and disruptions in signaling pathways. This necessitates a comprehensive review synthesizing recent advancements in molecular mechanisms, established biomarkers, as well as emerging ones like CDX2 for enhanced CRC assessment. Material and <b>Methods:</b> This review analyzes the last decade's literature and current guidelines to study CRC's molecular intricacies. It extends the analysis beyond traditional biomarkers to include emerging ones like CDX2, examining their interaction with carcinogenic mechanisms and molecular pathways, alongside reviewing current testing methodologies. <b>Results:</b> A multi-biomarker strategy, incorporating both traditional and emerging biomarkers like CDX2, is crucial for optimizing CRC management. This strategy elucidates the complex interaction between biomarkers and the tumor's molecular pathways, significantly influencing prognostic evaluations, therapeutic decision-making, and paving the way for personalized medicine in CRC. <b>Conclusions:</b> This review proposes CDX2 as an emerging prognostic biomarker and emphasizes the necessity of thorough molecular profiling for individualized treatment strategies. By enhancing CRC treatment approaches and prognostic evaluation, this effort marks a step forward in precision oncology, leveraging an enriched understanding of tumor behavior.</p>","PeriodicalId":10171,"journal":{"name":"Chirurgia","volume":"119 2","pages":"136-155"},"PeriodicalIF":0.8,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140920943","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact on Long-term Survival of a Standardized Histopathological Protocol on the R1 Incidence in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma. 胰腺十二指肠切除术中胰腺导管腺癌 R1 发生率的标准化组织病理学方案对长期生存的影响
IF 0.6 Q4 SURGERY Pub Date : 2024-04-01 DOI: 10.21614/chirurgia.2024.v.119.i.2.p.171
Emil Moiş, Florin Graur, Cosmin Puia, Iulia Vlad, Septimiu Moldovan, Cristina Paula Ursu, Vlad-Ionuţ Nechita, Dan Vălean, Luminiţa Furcea, Aida Puia, Florin Zaharie, Călin Popa, Raluca Bodea, Cornel Iancu, Ioana Rusu, Nadim Al Hajjar

Background: Pancreatic Ductal Adenocarcinoma (PDAC) is a pathology with a very poor prognostic, the only curative treatment option being surgery, in association with chemotherapy. This study aims to assess the influence that the use of a standardized pathology report after a pancreaticoduodenectomy (PD) has on the R1 margins rate and the impact that this has on long term survival. Material and Methods: We included 116 patients admitted to the Regional Institute of Gastroenterology and Hepatology Prof. Dr. O. Fodor Cluj Napoca, who underwent PD for PDAC (Pancreatic Ductal Adenocarcinoma) between January 2012 and May 2017. We divided them in two groups: 59 patients for which a nonstandardized histopathological protocol was used and 57 patients for which a standardized protocol was implemented. We considered a margin to be R1 when there were tumor cells at ¤ 1 mm from the resection margin. Results: The R1 percentage in the first group of patients was of 39%, while the R1 resection rate in the second group was of 68.4%. The median survival rate was similar in the two groups, with no statistically significant difference between them, but in the prospective study when comparing R0 vs R1 margins there was a statistically differences in 5 year OS with a p-value = 0.03. Conclusion: The use of a standardized pathology report reveals a significant increase in R1 resection rates. Also study revealed not only increasing R1 incidence when using a standardized histopathology report, but also that those margins (R1) playing a determinant role in 5-year OS. The mesopancreas is the most frequently R1 resection margin.

背景:胰腺导管腺癌(PDAC)是一种预后极差的病理类型,唯一的根治性治疗方案是手术和化疗。本研究旨在评估胰十二指肠切除术(PD)后使用标准化病理报告对 R1 切缘率的影响以及对长期生存的影响。材料和方法:我们纳入了 2012 年 1 月至 2017 年 5 月期间在克卢日那波卡地区胃肠病学和肝病学研究所(Prof. Dr. O. Fodor Cluj Napoca)接受胰十二指肠切除术(PDAC,胰腺导管腺癌)的 116 名患者。我们将他们分为两组:采用非标准化组织病理学方案的 59 例患者和采用标准化方案的 57 例患者。当肿瘤细胞距离切除边缘Â ¤ 1 mm时,我们认为边缘为R1。结果第一组患者的R1切除率为39%,而第二组患者的R1切除率为68.4%。两组患者的中位生存率相似,在统计学上没有显著差异,但在前瞻性研究中,比较 R0 与 R1 边缘时,5 年 OS 有统计学差异,P 值 = 0.03。结论标准化病理报告的使用表明,R1切除率显著增加。研究还显示,使用标准化组织病理报告不仅会增加 R1 的发生率,而且这些边缘(R1)对 5 年的 OS 起着决定性作用。胰腺间质是最常见的R1切除边缘。
{"title":"Impact on Long-term Survival of a Standardized Histopathological Protocol on the R1 Incidence in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma.","authors":"Emil Moiş, Florin Graur, Cosmin Puia, Iulia Vlad, Septimiu Moldovan, Cristina Paula Ursu, Vlad-Ionuţ Nechita, Dan Vălean, Luminiţa Furcea, Aida Puia, Florin Zaharie, Călin Popa, Raluca Bodea, Cornel Iancu, Ioana Rusu, Nadim Al Hajjar","doi":"10.21614/chirurgia.2024.v.119.i.2.p.171","DOIUrl":"https://doi.org/10.21614/chirurgia.2024.v.119.i.2.p.171","url":null,"abstract":"<p><p><b>Background:</b> Pancreatic Ductal Adenocarcinoma (PDAC) is a pathology with a very poor prognostic, the only curative treatment option being surgery, in association with chemotherapy. This study aims to assess the influence that the use of a standardized pathology report after a pancreaticoduodenectomy (PD) has on the R1 margins rate and the impact that this has on long term survival. Material and <b>Methods:</b> We included 116 patients admitted to the Regional Institute of Gastroenterology and Hepatology Prof. Dr. O. Fodor Cluj Napoca, who underwent PD for PDAC (Pancreatic Ductal Adenocarcinoma) between January 2012 and May 2017. We divided them in two groups: 59 patients for which a nonstandardized histopathological protocol was used and 57 patients for which a standardized protocol was implemented. We considered a margin to be R1 when there were tumor cells at ¤ 1 mm from the resection margin. <b>Results:</b> The R1 percentage in the first group of patients was of 39%, while the R1 resection rate in the second group was of 68.4%. The median survival rate was similar in the two groups, with no statistically significant difference between them, but in the prospective study when comparing R0 vs R1 margins there was a statistically differences in 5 year OS with a p-value = 0.03. Conclusion: The use of a standardized pathology report reveals a significant increase in R1 resection rates. Also study revealed not only increasing R1 incidence when using a standardized histopathology report, but also that those margins (R1) playing a determinant role in 5-year OS. The mesopancreas is the most frequently R1 resection margin.</p>","PeriodicalId":10171,"journal":{"name":"Chirurgia","volume":"119 2","pages":"171-183"},"PeriodicalIF":0.6,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140920999","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact Of Comorbidities On Outcomes And Healthcare Costs Of Open Inguinal Hernia Repair In Patients With Diabetes Mellitus. 合并症对糖尿病患者开放性腹股沟疝修补术疗效和医疗成本的影响
IF 0.8 Q4 SURGERY Pub Date : 2024-04-01 DOI: 10.21614/chirurgia.2024.v.119.i.2.p.227
Marian Madalin Racareanu, Silviu Daniel Preda, Ștefan Patrascu, Adina Turcu-Stiolica, Sandu Ramboiu, Dragoş Nicolae Margaritescu, Dan Cartu, Petru Radu, Styliani Laskou, Konstantinos Sapalidis, Valeriu Surlin

Introduction: Inguinal hernia management in patients with diabetes mellitus (DM) and comorbidities presents challenges due to potential impacts on wound healing and infection risk. This study evaluates the influence of additional comorbidities on outcomes following open inguinal hernia repair in DM patients.

Material and methods: A retrospective cohort study was conducted at Craiova Emergency Clinical County Hospital from 2015 to 2020. Patients with documented DM undergoing hernia repair were categorized into two groups based on comorbidity status. Data on presentation mode, hernia type, comorbidities, hospitalization, operative details, postoperative outcomes, and costs were collected and analyzed statistically.

Results: Among 38 DM patients undergoing hernia repair, 16 were in Group A (DM alone) and 22 in Group B (DM with comorbidities). Group B patients were older (p = 0.0002) and more likely to present emergently (OR: 13.81, p=0.0148) with incarcerated (OR: 22.733, p=0.0339) or strangulated hernias (OR: 9.4545, p=0.0390). Group B had longer hospitalizations (p=0.00132) and higher hospitalization costs (p = 0.00262).

Conclusions: DM patients with comorbidities are at higher risk for complex hernias and prolonged hospitalizations. Pulmonary fibrosis emerges as a significant comorbidity requiring specific perioperative strategies. Tailored preoperative assessments and care plans can optimize outcomes.

简介:糖尿病(DM)患者和合并症患者腹股沟疝的治疗因其对伤口愈合和感染风险的潜在影响而面临挑战。本研究评估了其他合并症对糖尿病患者腹股沟疝开放性修复术后效果的影响:2015 年至 2020 年,克拉约瓦县临床急诊医院开展了一项回顾性队列研究。根据合并症状况将接受疝修补术的DM患者分为两组。收集并统计分析了发病方式、疝气类型、合并症、住院情况、手术细节、术后结果和费用等数据:结果:在接受疝修补术的 38 名糖尿病患者中,A 组(单纯糖尿病)16 人,B 组(有合并症的糖尿病)22 人。B 组患者年龄更大(p = 0.0002),更有可能急诊就诊(OR:13.81,p=0.0148),并伴有嵌顿(OR:22.733,p=0.0339)或绞窄性疝气(OR:9.4545,p=0.0390)。B组住院时间更长(p=0.00132),住院费用更高(p=0.00262):结论:有合并症的糖尿病患者发生复杂性疝气和住院时间延长的风险较高。肺纤维化是一种重要的合并症,需要特殊的围手术期策略。量身定制的术前评估和护理计划可优化治疗效果。
{"title":"Impact Of Comorbidities On Outcomes And Healthcare Costs Of Open Inguinal Hernia Repair In Patients With Diabetes Mellitus.","authors":"Marian Madalin Racareanu, Silviu Daniel Preda, Ștefan Patrascu, Adina Turcu-Stiolica, Sandu Ramboiu, Dragoş Nicolae Margaritescu, Dan Cartu, Petru Radu, Styliani Laskou, Konstantinos Sapalidis, Valeriu Surlin","doi":"10.21614/chirurgia.2024.v.119.i.2.p.227","DOIUrl":"https://doi.org/10.21614/chirurgia.2024.v.119.i.2.p.227","url":null,"abstract":"<p><strong>Introduction: </strong>Inguinal hernia management in patients with diabetes mellitus (DM) and comorbidities presents challenges due to potential impacts on wound healing and infection risk. This study evaluates the influence of additional comorbidities on outcomes following open inguinal hernia repair in DM patients.</p><p><strong>Material and methods: </strong>A retrospective cohort study was conducted at Craiova Emergency Clinical County Hospital from 2015 to 2020. Patients with documented DM undergoing hernia repair were categorized into two groups based on comorbidity status. Data on presentation mode, hernia type, comorbidities, hospitalization, operative details, postoperative outcomes, and costs were collected and analyzed statistically.</p><p><strong>Results: </strong>Among 38 DM patients undergoing hernia repair, 16 were in Group A (DM alone) and 22 in Group B (DM with comorbidities). Group B patients were older (p = 0.0002) and more likely to present emergently (OR: 13.81, p=0.0148) with incarcerated (OR: 22.733, p=0.0339) or strangulated hernias (OR: 9.4545, p=0.0390). Group B had longer hospitalizations (p=0.00132) and higher hospitalization costs (p = 0.00262).</p><p><strong>Conclusions: </strong>DM patients with comorbidities are at higher risk for complex hernias and prolonged hospitalizations. Pulmonary fibrosis emerges as a significant comorbidity requiring specific perioperative strategies. Tailored preoperative assessments and care plans can optimize outcomes.</p>","PeriodicalId":10171,"journal":{"name":"Chirurgia","volume":"119 2","pages":"227-234"},"PeriodicalIF":0.8,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141562829","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Role of Palliative Surgery in the Management of Acute Intestinal Obstruction Secondary to Peritoneal Carcinomatosis. 姑息手术在腹膜癌继发急性肠梗阻治疗中的作用。
IF 0.6 Q4 SURGERY Pub Date : 2024-04-01 DOI: 10.21614/chirurgia.2024.v.119.i.2.p.218
Bharath Kumar Bhat, Amitabh Yadav, Samiran Nundy

Introduction: Acute intestinal obstruction secondary to extensive peritoneal carcinomatosis is an end stage event. The role of palliative surgery in these patients is debatable in view of the anticipated severe complications and its doubtful role in achieving adequate palliation. The primary objective of our study was to evaluate the feasibility and ability of patients to resume oral nutrition after palliative surgery for acute intestinal obstruction due to peritoneal carcinomatosis. Patients and Methods: It is an observational study in which we retrospectively reviewed the data from a prospectively maintained clinical database of 40 patients. The predefined pre- and intraoperative variables were obtained. The immediate outcome variables like postoperative complications, length of hospital stay, and mortality were analyzed. The short-term outcomes at 3 months in the form of survival, ability to resume enteral nutrition were analyzed. Results: Among the 40 patients 18 were males and 22 females. Ovarian cancer was the most common primary (27.5%) in the study. Twelve patients had acute intestinal obstruction as their first presentation without any past events and 25 (62.5%) patients had been operated on previously or received adjuvant systemic treatment. The palliative surgical option was technically feasible in 37 (93.5%) patients. The median length of hospitalization for the patients who were discharged was 10 days with a range of 6-18 days. Six (15%) patients died in the postoperative period. Severe post-operative complications were seen in 9 (26.4%) patients. Among the patients (n=34) discharged 26 (76.4%) were alive at 3 months. In those who were alive, 21 (80.7%) of them were on some form of oral nutrition at 3 months. Conclusion: Palliative surgery in patients with acute intestinal obstruction secondary to peritoneal carcinomatosis is feasible with acceptable morbidity and mortality. The enteral nutrition can be restored in the majority of these patients.

简介继发于广泛腹膜癌的急性肠梗阻是一种终末期疾病。鉴于预期的严重并发症以及姑息性手术在实现充分姑息方面的作用存疑,姑息性手术在这些患者中的作用值得商榷。我们研究的主要目的是评估腹膜癌导致的急性肠梗阻姑息手术后患者恢复口服营养的可行性和能力。患者和方法:这是一项观察性研究,我们回顾性审查了前瞻性临床数据库中 40 名患者的数据。我们获得了术前和术中的预定变量。对术后并发症、住院时间和死亡率等直接结果变量进行了分析。还分析了 3 个月后的短期疗效,包括存活率和恢复肠内营养的能力。结果:40 名患者中有 18 名男性和 22 名女性。卵巢癌是研究中最常见的原发性癌症(27.5%)。12名患者首次出现急性肠梗阻,且无任何既往史,25名患者(62.5%)曾接受过手术或辅助系统治疗。37例(93.5%)患者在技术上可以选择姑息性手术。出院患者的中位住院时间为 10 天,范围为 6-18 天。6名(15%)患者在术后死亡。术后出现严重并发症的患者有 9 人(26.4%)。在出院的患者(34 人)中,有 26 人(76.4%)在 3 个月后存活。其中 21 人(80.7%)在 3 个月时仍在接受某种形式的口服营养。结论对腹膜癌继发急性肠梗阻患者进行姑息手术是可行的,其发病率和死亡率均可接受。大多数患者可以恢复肠内营养。
{"title":"The Role of Palliative Surgery in the Management of Acute Intestinal Obstruction Secondary to Peritoneal Carcinomatosis.","authors":"Bharath Kumar Bhat, Amitabh Yadav, Samiran Nundy","doi":"10.21614/chirurgia.2024.v.119.i.2.p.218","DOIUrl":"10.21614/chirurgia.2024.v.119.i.2.p.218","url":null,"abstract":"<p><p><b>Introduction:</b> Acute intestinal obstruction secondary to extensive peritoneal carcinomatosis is an end stage event. The role of palliative surgery in these patients is debatable in view of the anticipated severe complications and its doubtful role in achieving adequate palliation. The primary objective of our study was to evaluate the feasibility and ability of patients to resume oral nutrition after palliative surgery for acute intestinal obstruction due to peritoneal carcinomatosis. Patients and <b>Methods:</b> It is an observational study in which we retrospectively reviewed the data from a prospectively maintained clinical database of 40 patients. The predefined pre- and intraoperative variables were obtained. The immediate outcome variables like postoperative complications, length of hospital stay, and mortality were analyzed. The short-term outcomes at 3 months in the form of survival, ability to resume enteral nutrition were analyzed. <b>Results:</b> Among the 40 patients 18 were males and 22 females. Ovarian cancer was the most common primary (27.5%) in the study. Twelve patients had acute intestinal obstruction as their first presentation without any past events and 25 (62.5%) patients had been operated on previously or received adjuvant systemic treatment. The palliative surgical option was technically feasible in 37 (93.5%) patients. The median length of hospitalization for the patients who were discharged was 10 days with a range of 6-18 days. Six (15%) patients died in the postoperative period. Severe post-operative complications were seen in 9 (26.4%) patients. Among the patients (n=34) discharged 26 (76.4%) were alive at 3 months. In those who were alive, 21 (80.7%) of them were on some form of oral nutrition at 3 months. Conclusion: Palliative surgery in patients with acute intestinal obstruction secondary to peritoneal carcinomatosis is feasible with acceptable morbidity and mortality. The enteral nutrition can be restored in the majority of these patients.</p>","PeriodicalId":10171,"journal":{"name":"Chirurgia","volume":"119 2","pages":"218-226"},"PeriodicalIF":0.6,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140921123","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Quality of Life in Patients Undergoing Emergency Surgery for Complex Colorectal Cancer: Protocol and Piloting of the Surgical Utilization and Recovery Patterns for Advanced Stage Colorectal Cancer Study. 复杂结直肠癌急诊手术患者的生活质量:晚期结直肠癌手术利用和康复模式研究的协议和试点。
IF 0.6 Q4 SURGERY Pub Date : 2024-04-01 DOI: 10.21614/chirurgia.2024.v.119.i.2.p.156
Cezar Ciubotaru, Radu Cristian Poenaru, Mircea Beuran, Traian Pătraşcu, Claudiu Ștefan Turculeţ, Gabriel Constantinescu, Sorin Hostiuc, Alin Moldoveanu, Ionuţ Negoi

Introduction: Globally, cancer is the leading cause of mortality, with colorectal neoplasia ranking third in terms of incidence and mortality worldwide. Patients face disease- and treatment-specific impacts, which can significantly influence their quality of life (QoL). Aim: This study aimed to propose a protocol to measure in-hospital and long-term QoL in patients with complicated colorectal cancer (CRC). Material and Methods: multicenter prospective observational cohort study. Results: QoL is a multidimensional concept that includes criteria for physical, mental, emotional, and social functionality as perceived by the patient. Periodically evaluating QoL offers measurable and objective tools to intervene at the appropriate time to decrease the Years of Life Lost and Years Lived with Disabilities for CRC patients. However, a structured and functional system requires dedicated and common institutional effort. A pilot study using this protocol included 69 patients, 65.12+-10.92 years, M:F ratio = 56.5:43.5%. Surgical procedure was right hemicolectomy, left colectomy, transverse colectomy, sigmoidectomy, total colectomy, rectal resection, and colorectal resection with stoma (ileostomy or colostomy) in 21.7%, 11.6%, 2.9%, 11.6%, 1.4%, 23.2%, and 27.5% of the cases, respectively. The mean Global Health Status Score, Symptom Score, and Functional Score was 82.36+-18.60, 11.89+-10.27, and 86.27, 74.50-94.11, respectively. Conclusions: CRC diagnosis has major effects on patients physical and psychological status, and concentrated efforts should be made by the involved medical team and healthcare systems to improve QoL throughout the treatment pathway.

导言:在全球范围内,癌症是导致死亡的主要原因,而结直肠肿瘤在全球发病率和死亡率中排名第三。患者面临着与疾病和治疗相关的影响,这些影响会严重影响他们的生活质量(QoL)。目的:本研究旨在提出一套方案,用于测量复杂性结直肠癌(CRC)患者的院内和长期 QoL。材料与方法:多中心前瞻性观察队列研究。研究结果QoL 是一个多维概念,包括患者感知的身体、心理、情感和社会功能标准。定期评估 QoL 可提供可衡量的客观工具,以便在适当的时候进行干预,减少 CRC 患者的生命损失年数和残疾生存年数。然而,一个结构合理、功能完善的系统需要各机构的共同努力。使用该方案进行的试点研究包括 69 名患者,年龄为 65.12+-10.92 岁,男女比例为 56.5:43.5%。手术方式为右半结肠切除术、左结肠切除术、横结肠切除术、乙状结肠切除术、全结肠切除术、直肠切除术和结直肠切除术,造口(回肠造口术或结肠造口术)分别占 21.7%、11.6%、2.9%、11.6%、1.4%、23.2% 和 27.5%。总体健康状况评分、症状评分和功能评分的平均值分别为 82.36+-18.60、11.89+-10.27 和 86.27、74.50-94.11。结论确诊为 CRC 会对患者的身体和心理状态产生重大影响,相关医疗团队和医疗系统应在整个治疗过程中努力改善患者的 QoL。
{"title":"Quality of Life in Patients Undergoing Emergency Surgery for Complex Colorectal Cancer: Protocol and Piloting of the Surgical Utilization and Recovery Patterns for Advanced Stage Colorectal Cancer Study.","authors":"Cezar Ciubotaru, Radu Cristian Poenaru, Mircea Beuran, Traian Pătraşcu, Claudiu Ștefan Turculeţ, Gabriel Constantinescu, Sorin Hostiuc, Alin Moldoveanu, Ionuţ Negoi","doi":"10.21614/chirurgia.2024.v.119.i.2.p.156","DOIUrl":"10.21614/chirurgia.2024.v.119.i.2.p.156","url":null,"abstract":"<p><p><b>Introduction:</b> Globally, cancer is the leading cause of mortality, with colorectal neoplasia ranking third in terms of incidence and mortality worldwide. Patients face disease- and treatment-specific impacts, which can significantly influence their quality of life (QoL). Aim: This study aimed to propose a protocol to measure in-hospital and long-term QoL in patients with complicated colorectal cancer (CRC). Material and <b>Methods:</b> multicenter prospective observational cohort study. <b>Results:</b> QoL is a multidimensional concept that includes criteria for physical, mental, emotional, and social functionality as perceived by the patient. Periodically evaluating QoL offers measurable and objective tools to intervene at the appropriate time to decrease the Years of Life Lost and Years Lived with Disabilities for CRC patients. However, a structured and functional system requires dedicated and common institutional effort. A pilot study using this protocol included 69 patients, 65.12+-10.92 years, M:F ratio = 56.5:43.5%. Surgical procedure was right hemicolectomy, left colectomy, transverse colectomy, sigmoidectomy, total colectomy, rectal resection, and colorectal resection with stoma (ileostomy or colostomy) in 21.7%, 11.6%, 2.9%, 11.6%, 1.4%, 23.2%, and 27.5% of the cases, respectively. The mean Global Health Status Score, Symptom Score, and Functional Score was 82.36+-18.60, 11.89+-10.27, and 86.27, 74.50-94.11, respectively. <b>Conclusions:</b> CRC diagnosis has major effects on patients physical and psychological status, and concentrated efforts should be made by the involved medical team and healthcare systems to improve QoL throughout the treatment pathway.</p>","PeriodicalId":10171,"journal":{"name":"Chirurgia","volume":"119 2","pages":"156-170"},"PeriodicalIF":0.6,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140921193","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Low Anterior Resection Syndrome. Anatomical Changes after Anterior Rectal Resection. 低位前切除综合征。直肠前切除术后的解剖学变化。
IF 0.6 Q4 SURGERY Pub Date : 2024-04-01 DOI: 10.21614/chirurgia.2024.v.119.i.2.p.125
Virgiliu-Mihail Prunoiu, Mircea-Niculae Brătucu, Dragoş Garofil, Victor Strâmbu, Eugen Brătucu, Laurenţiu Simion, Eduard-Georgian Chiru, Petru Adrian Radu

In this editorial, the authors bring to the attention of surgeons a personal point of view with the intention of offering a series of anatomical arguments to explain the high rate of functional complications following ultralow rectal resections, resections dominated by faecal incontinence of various intensities. Having as a starting point the anatomy of the pelvic floor and the posterior perineum, the authors are concerned with the functional outcomes of the sphincter-saving anterior rectal resection, regarding the low and ultralow resection. Technically, a conservative surgery for low rectal cancer has been currently performed. If 25 years ago the abdominoperineal resection was the gold standard for rectal cancer located under 7cm from the anal verge, nowadays the preservation of the anal canal as a partner for colon anastomosis has been accomplished. Progressively, from a desire to preserve the normal passage of stool into the anal canal, as anatomically and physiologically as possible, the distal limit of resection was lowered to 2-4 cm from the anal verge and ultra-low anastomoses were created, within the anal sphincter complex. The stated goal: keep the oncological safety standard and, at the same time, avoid definitive colostomy. Starting from the normal anatomy of the pelvic floor and the anorectal segment, the authors take a look at the alterations of the visceral, muscular, and nerve structures as a consequence of the low anterior resection and, particularly, the ultralow anterior resection. A significant degree of functional outcomes regarding defecation, with the onset of marked disabilities of anal continence, the major consequence being anal incontinence (30-70%), have been noticed. The authors go under review for the main anatomical and physiological changes that accompany anterior rectal resection. Conclusions: Thus, the following questions arise: what is the lower limit of resection to avoid total fecal incontinence? Is total incontinence a greater handicap than colostomy or is it not? The answers cannot be supported by solid arguments at this time, but the need to initiate future studies dedicated to this problem emerges.

在这篇社论中,作者向外科医生提出了个人观点,旨在提供一系列解剖学论据,解释超低位直肠切除术后功能并发症高发的原因,这些切除术以不同程度的大便失禁为主。作者以骨盆底和会阴后部的解剖学为出发点,关注低位和超低位直肠切除术中节省括约肌的直肠前切除术的功能性结果。从技术上讲,目前对低位直肠癌采取的是保守手术。如果说 25 年前,腹会阴切除术是治疗距离肛门边缘 7 厘米以下直肠癌的金标准,那么如今,保留肛管作为结肠吻合术的伴侣已经实现。从解剖学和生理学角度出发,尽可能保留粪便进入肛管的正常通道,切除术的远端界限逐渐降低到距肛缘 2-4 厘米,并在肛门括约肌复合体内建立超低吻合。其既定目标是:保持肿瘤安全标准,同时避免明确的结肠造口术。作者从盆底和肛门直肠的正常解剖结构入手,分析了低位前切除术,尤其是超低位前切除术对内脏、肌肉和神经结构造成的改变。他们注意到排便功能发生了很大程度的改变,肛门失禁现象明显,主要后果是肛门失禁(30%-70%)。作者回顾了直肠前切除术带来的主要解剖和生理变化。最后得出结论:因此,出现了以下问题:避免大便完全失禁的切除下限是多少?大便完全失禁是否比结肠造口术造成更大的障碍?这些问题的答案目前还没有确凿的论据支持,但今后有必要启动专门针对这一问题的研究。
{"title":"Low Anterior Resection Syndrome. Anatomical Changes after Anterior Rectal Resection.","authors":"Virgiliu-Mihail Prunoiu, Mircea-Niculae Brătucu, Dragoş Garofil, Victor Strâmbu, Eugen Brătucu, Laurenţiu Simion, Eduard-Georgian Chiru, Petru Adrian Radu","doi":"10.21614/chirurgia.2024.v.119.i.2.p.125","DOIUrl":"https://doi.org/10.21614/chirurgia.2024.v.119.i.2.p.125","url":null,"abstract":"<p><p>In this editorial, the authors bring to the attention of surgeons a personal point of view with the intention of offering a series of anatomical arguments to explain the high rate of functional complications following ultralow rectal resections, resections dominated by faecal incontinence of various intensities. Having as a starting point the anatomy of the pelvic floor and the posterior perineum, the authors are concerned with the functional outcomes of the sphincter-saving anterior rectal resection, regarding the low and ultralow resection. Technically, a conservative surgery for low rectal cancer has been currently performed. If 25 years ago the abdominoperineal resection was the gold standard for rectal cancer located under 7cm from the anal verge, nowadays the preservation of the anal canal as a partner for colon anastomosis has been accomplished. Progressively, from a desire to preserve the normal passage of stool into the anal canal, as anatomically and physiologically as possible, the distal limit of resection was lowered to 2-4 cm from the anal verge and ultra-low anastomoses were created, within the anal sphincter complex. The stated goal: keep the oncological safety standard and, at the same time, avoid definitive colostomy. Starting from the normal anatomy of the pelvic floor and the anorectal segment, the authors take a look at the alterations of the visceral, muscular, and nerve structures as a consequence of the low anterior resection and, particularly, the ultralow anterior resection. A significant degree of functional outcomes regarding defecation, with the onset of marked disabilities of anal continence, the major consequence being anal incontinence (30-70%), have been noticed. The authors go under review for the main anatomical and physiological changes that accompany anterior rectal resection. <b>Conclusions:</b> Thus, the following questions arise: what is the lower limit of resection to avoid total fecal incontinence? Is total incontinence a greater handicap than colostomy or is it not? The answers cannot be supported by solid arguments at this time, but the need to initiate future studies dedicated to this problem emerges.</p>","PeriodicalId":10171,"journal":{"name":"Chirurgia","volume":"119 2","pages":"125-135"},"PeriodicalIF":0.6,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140921000","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pelvic Exenteration - Past, Present and Future. 骨盆扩张术--过去、现在和未来。
IF 0.8 Q4 SURGERY Pub Date : 2024-04-01 DOI: 10.21614/chirurgia.2024.v.119.i.2.p.201
Laura Duduş, Corina E Minciună, Ștefan Tudor, Monica Lăcătuş, Cătălin Vasilescu

Background: Bearing in mind that the open procedure is already validated by multiple studies, the article aims to prove that pelvic exenteration performed in a minimally invasive fashion might offer better survival and to potentially identify prognostic factors for the outcome of these patients. Material and Methods: Data regarding past and present classifications and surgical indications are presented. Patient data were collected retrospectively. Results: The most frequent diseases treated with pelvic exenteration, in terms of the hystological type, were gynecological malignancy and squamous cell carcinoma. Recurrent pelvic disease was found in 68.2% of patients. R0 resection was achieved in 72.7% of patients in the MI group, and in 73.7% of patients in the OP group. Peri-operative morbidity was reported to be 56.6% for open surgery, and 18.1% for minimally invasive. Average DFS was 20.15 months, ranging from 1.5 to 70.3 months, while the OS was calculated to be 38.1 months (0.33 1508) up until November 2023. Conclusion: Pelvic exenteration is a continuously improving surgical procedure, open approach being favored to minimally invasive one. On the other hand, hospitalization and morbidity are reduced when choosing the latter. R0 and lymph node status are important predictors for overall survival, as well as major early postoperative complications. All in all, pelvic exenteration is still a promising surgical procedure to extend cancer patients lives.

背景:鉴于开放手术已被多项研究证实,本文旨在证明以微创方式进行骨盆扩张术可能会提高患者的存活率,并找出影响这些患者预后的潜在因素。材料与方法:本文介绍了有关过去和现在的分类及手术适应症的数据。患者数据为回顾性收集。结果就子宫类型而言,最常采用盆腔外扩张术治疗的疾病是妇科恶性肿瘤和鳞状细胞癌。68.2%的患者盆腔疾病复发。MI组72.7%的患者实现了R0切除,OP组73.7%的患者实现了R0切除。据报道,开放手术的围手术期发病率为56.6%,微创手术为18.1%。平均 DFS 为 20.15 个月,从 1.5 个月到 70.3 个月不等,而截至 2023 年 11 月的 OS 为 38.1 个月(0.33 1508)。结论骨盆外展术是一种不断改进的手术方法,开放式方法优于微创方法。另一方面,选择后者可减少住院时间和发病率。R0和淋巴结状态是预测总生存率以及术后早期主要并发症的重要指标。总而言之,盆腔外扩张术仍是一种有希望延长癌症患者生命的手术方法。
{"title":"Pelvic Exenteration - Past, Present and Future.","authors":"Laura Duduş, Corina E Minciună, Ștefan Tudor, Monica Lăcătuş, Cătălin Vasilescu","doi":"10.21614/chirurgia.2024.v.119.i.2.p.201","DOIUrl":"10.21614/chirurgia.2024.v.119.i.2.p.201","url":null,"abstract":"<p><p><b>Background:</b> Bearing in mind that the open procedure is already validated by multiple studies, the article aims to prove that pelvic exenteration performed in a minimally invasive fashion might offer better survival and to potentially identify prognostic factors for the outcome of these patients. Material and <b>Methods:</b> Data regarding past and present classifications and surgical indications are presented. Patient data were collected retrospectively. <b>Results:</b> The most frequent diseases treated with pelvic exenteration, in terms of the hystological type, were gynecological malignancy and squamous cell carcinoma. Recurrent pelvic disease was found in 68.2% of patients. R0 resection was achieved in 72.7% of patients in the MI group, and in 73.7% of patients in the OP group. Peri-operative morbidity was reported to be 56.6% for open surgery, and 18.1% for minimally invasive. Average DFS was 20.15 months, ranging from 1.5 to 70.3 months, while the OS was calculated to be 38.1 months (0.33 1508) up until November 2023. Conclusion: Pelvic exenteration is a continuously improving surgical procedure, open approach being favored to minimally invasive one. On the other hand, hospitalization and morbidity are reduced when choosing the latter. R0 and lymph node status are important predictors for overall survival, as well as major early postoperative complications. All in all, pelvic exenteration is still a promising surgical procedure to extend cancer patients lives.</p>","PeriodicalId":10171,"journal":{"name":"Chirurgia","volume":"119 2","pages":"201-210"},"PeriodicalIF":0.8,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140921115","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Vascularized Omentum Lymph Node Transfer - A Key Point in the Lymphedema Management. 血管化网膜淋巴结转移--淋巴水肿治疗的关键点。
IF 0.6 Q4 SURGERY Pub Date : 2024-04-01 DOI: 10.21614/chirurgia.2024.v.119.i.2.p.191
Anca Bordianu, Ion Petre, Anca Bobircă, Florin Bobircă

Background: As an increased number of women beat breast cancer worldwide, the breast cancer related lymphedema has gained more attention recently. The vascularized omentum lymph node transfer has been approached as an useful tool for advanced and recurrent cases. The purpose of the paper is to emphasize the advantages and disadvantages of this method. Materials and Methods: This retrospective study consists of 17 patients known with breast cancer related lymphedema who received vascularized omentum lymph node transfer. Data was recorded between January 2022 and January 2023. Patients diagnosed with secondary lymphedema stage II or III, unresponsive to previous microsurgical lymphovenous bypass were included. Results: The most prevalent affected site was the left upper limb (59%), where edema was mainly identified in the forearm (75%). Nevertheless, more than half of the subjects have previously received lymphaticovenous anastomosis. The correlation between the stage of lymphedema and the postoperative reduction of the volume of the affected limb was -0.26, the slope to reached -0.33, with an intercept value of 2.64. The follow-up period showed reduced upper limb volume and an improved quality of life. Conclusion: Through an experienced hand, this versatile flap brings hope to breast cancer survivors with lymphedema.

背景:随着全球罹患乳腺癌的女性人数不断增加,与乳腺癌相关的淋巴水肿近来受到越来越多的关注。血管化网膜淋巴结转移被认为是治疗晚期和复发病例的有效手段。本文旨在强调这种方法的优缺点。材料和方法:这项回顾性研究包括 17 名已知患有乳腺癌相关淋巴水肿并接受了血管化网膜淋巴结转移的患者。数据记录时间为 2022 年 1 月至 2023 年 1 月。纳入的患者均被诊断为继发性淋巴水肿II期或III期,对之前的显微外科淋巴管搭桥术无反应。结果最常见的受影响部位是左上肢(59%),水肿主要发生在前臂(75%)。不过,半数以上的受试者曾接受过淋巴-静脉吻合术。淋巴水肿阶段与术后患肢体积缩小之间的相关性为-0.26,斜率达到-0.33,截距值为2.64。随访结果显示上肢体积缩小,生活质量提高。结论:通过经验丰富的医生,这种多功能皮瓣为患有淋巴水肿的乳腺癌幸存者带来了希望。
{"title":"The Vascularized Omentum Lymph Node Transfer - A Key Point in the Lymphedema Management.","authors":"Anca Bordianu, Ion Petre, Anca Bobircă, Florin Bobircă","doi":"10.21614/chirurgia.2024.v.119.i.2.p.191","DOIUrl":"https://doi.org/10.21614/chirurgia.2024.v.119.i.2.p.191","url":null,"abstract":"<p><p><b>Background:</b> As an increased number of women beat breast cancer worldwide, the breast cancer related lymphedema has gained more attention recently. The vascularized omentum lymph node transfer has been approached as an useful tool for advanced and recurrent cases. The purpose of the paper is to emphasize the advantages and disadvantages of this method. <b>Materials and Methods:</b> This retrospective study consists of 17 patients known with breast cancer related lymphedema who received vascularized omentum lymph node transfer. Data was recorded between January 2022 and January 2023. Patients diagnosed with secondary lymphedema stage II or III, unresponsive to previous microsurgical lymphovenous bypass were included. <b>Results:</b> The most prevalent affected site was the left upper limb (59%), where edema was mainly identified in the forearm (75%). Nevertheless, more than half of the subjects have previously received lymphaticovenous anastomosis. The correlation between the stage of lymphedema and the postoperative reduction of the volume of the affected limb was -0.26, the slope to reached -0.33, with an intercept value of 2.64. The follow-up period showed reduced upper limb volume and an improved quality of life. Conclusion: Through an experienced hand, this versatile flap brings hope to breast cancer survivors with lymphedema.</p>","PeriodicalId":10171,"journal":{"name":"Chirurgia","volume":"119 2","pages":"191-200"},"PeriodicalIF":0.6,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140921177","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Helicobacter pylori Infection at Crossroads between Specialties. 幽门螺杆菌感染在专科之间的交叉路口。
IF 0.6 Q4 SURGERY Pub Date : 2024-03-01 DOI: 10.21614/chirurgia.119.eC.2949
Roxana Florentina Chivu, Florin Bobirca, Dan Dumitrescu, Cristina Alexandru, Traian Patrascu

Background: Helicobacter pylori (H. pylori) infection is one of the major current public health problems, its incidence being high worldwide. This condition is associated with other pathologies such as peptic ulcer or gastric cancer, causing a real challenge for specialists in the medical field. Methods:We conducted a retrospective study that includes a cohort of 275 patients who performed EGD and were tested for the presence of H. pylori by the stool antigen test, between July 2022 and December 2023. Results:The cohort had an average age of 62.79 ± 13.8 years old, with a male predominance 156 patients (56.7%) and the most frequent lesion is antral gastritis (149 cases, 54.2%). Gastric ulcer in those with positive tests in H. pylori had a double incidence compared to those in which the infection is not present (19.7% vs. 9.2%, p=0.012). Conclusions:: H. pylori infection still remains a condition that can be complicated by various pathological conditions that can evolve from a slight erosion of the gastric mucosa to digestive neoplasia that require complex multidisciplinary treatments, which is why understanding the mechanisms and applying therapeutic resources as soon as possible is essential.

背景:幽门螺杆菌(H. pylori)感染是当前主要的公共卫生问题之一,在全世界的发病率都很高。这种病症与消化性溃疡或胃癌等其他病症相关,给医学领域的专家带来了真正的挑战。方法:我们开展了一项回顾性研究,研究对象包括 2022 年 7 月至 2023 年 12 月期间接受胃肠道造影术并通过粪便抗原检测发现幽门螺杆菌的 275 名患者。结果:该队列的平均年龄为(62.79±13.8)岁,男性患者居多,有 156 例(56.7%),最常见的病变是前胃炎(149 例,54.2%)。幽门螺杆菌检测呈阳性者的胃溃疡发病率是未感染者的两倍(19.7% 对 9.2%,P=0.012)。结论幽门螺杆菌感染仍然是一种可并发各种病理情况的疾病,可从轻微的胃黏膜糜烂演变为需要复杂的多学科治疗的消化系统肿瘤,这就是为什么了解幽门螺杆菌感染的机制并尽快应用治疗资源是至关重要的。
{"title":"Helicobacter pylori Infection at Crossroads between Specialties.","authors":"Roxana Florentina Chivu, Florin Bobirca, Dan Dumitrescu, Cristina Alexandru, Traian Patrascu","doi":"10.21614/chirurgia.119.eC.2949","DOIUrl":"10.21614/chirurgia.119.eC.2949","url":null,"abstract":"<p><p><b>Background:</b> Helicobacter pylori (H. pylori) infection is one of the major current public health problems, its incidence being high worldwide. This condition is associated with other pathologies such as peptic ulcer or gastric cancer, causing a real challenge for specialists in the medical field. <b>Methods:</b>We conducted a retrospective study that includes a cohort of 275 patients who performed EGD and were tested for the presence of H. pylori by the stool antigen test, between July 2022 and December 2023. <b>Results:</b>The cohort had an average age of 62.79 ± 13.8 years old, with a male predominance 156 patients (56.7%) and the most frequent lesion is antral gastritis (149 cases, 54.2%). Gastric ulcer in those with positive tests in H. pylori had a double incidence compared to those in which the infection is not present (19.7% vs. 9.2%, p=0.012). <b>Conclusions:</b>: H. pylori infection still remains a condition that can be complicated by various pathological conditions that can evolve from a slight erosion of the gastric mucosa to digestive neoplasia that require complex multidisciplinary treatments, which is why understanding the mechanisms and applying therapeutic resources as soon as possible is essential.</p>","PeriodicalId":10171,"journal":{"name":"Chirurgia","volume":"119 eCollection","pages":"1"},"PeriodicalIF":0.6,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140118930","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Chirurgia
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1